Recombinant human antibodies against the reverse transcriptase of human immunodeficiency virus type-1

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1648, Issue 1-2, 2003, Pages 154-163

  Herschhorn, Alon ^a   Admon, Arie ^b   Hizi, Amnon ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Inhibition of enzymatic activity; Phage display; ScFv antibody

Indexed keywords

DNA DIRECTED DNA POLYMERASE; ENZYME ANTIBODY; RECOMBINANT ANTIBODY; RECOMBINANT RNA DIRECTED DNA POLYMERASE ANTIBODY; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; PEPTIDE LIBRARY; RECOMBINANT PROTEIN; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; ANTIBODY SPECIFICITY; DRUG ANTAGONISM; GENETICS; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CLONING, MOLECULAR; GENES, IMMUNOGLOBULIN; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; RECOMBINANT PROTEINS;

EID: 1242341271     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-9639(03)00118-3     Document Type: Article

References (39)

1. Morgan R.A. Genetic strategies to inhibit HIV. Mol. Med. Today. 5:1999;454-458.
2. Wong-Staal F., Poeschla E.M., Looney D.J. A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA. Hum. Gene Ther. 9:1998;2407-2425.
3. Liu D., Donegan J., Nuovo G., Mitra D., Laurence J. Stable human immunodeficiency virus type 1 (HIV-1) resistance in transformed CD4+ monocytic cells treated with multitargeting HIV-1 antisense sequences incorporated into U1 snRNA. J. Virol. 71:1997;4079-4085.
4. Lee S.W., Gallardo H.F., Gilboa E., Smith C. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. J. Virol. 68:1994;8254-8264.
5. Morgan R.A., Walker R. Gene therapy for AIDS using retroviral-mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins. Hum. Gene Ther. 7:1996;1281-1306.
6. Goncalves J., Silva F., Freitas-Vieira A., Santa-Marta M., Malho R., Yang X., Gabuzda D., Barbas C. III Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication. J. Biol. Chem. 277:2002;32036-32045.
7. Marasco W.A. Intrabodies as antiviral agents. Curr. Top. Microbiol. Immunol. 260:2001;247-270.
8. Rondon I.J., Marasco W.A. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu. Rev. Microbiol. 51:1997;257-283.
9. Coffin J., Hugues S., Varmus H. Retroviruses. 1997;Cold Spring Harbor Press, Cold Spring Harbor, NY.
10. Shaheen F., Duan L., Zhu M., Bagasra O., Pomerantz R.J. Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle. J. Virol. 70:1996;3392-3400.
11. Chiba J., Yamaguchi A., Suzuki Y., Nakano M., Zhu W., Ohba H., Saito A., Shinagawa H., Yamakawa Y., Kobayashi T., Kurata T. A novel neutralization epitope on the 'thumb' subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by a monoclonal antibody. J. Gen. Virol. 77:1996;2921-2929.
12. Chiba J., Nakano M., Suzuki Y., Aoyama K., Ohba H., Kobayashi T., Yasuda A., Kojima A., Kurata T. Generation of neutralizing antibody to the reverse transcriptase of human immunodeficiency virus type 1 by immunizing of mice with an infectious vaccinia virus recombinant. J. Immunol. Methods. 207:1997;53-60.
13. Ferns R.B., Partridge J.C., Tisdale M., Hunt N., Tedder R.S. Monoclonal antibodies define linear and conformational epitopes of HIV-1 pol gene products. AIDS Res. Hum. Retrovir. 7:1991;307-313.
14. Ohba H., Soga T., Tomozawa T., Nishikawa Y., Yasuda A., Kojima A., Kurata T., Chiba J. An immunodominant neutralization epitope on the 'thumb' subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by phage display antibodies. J. Gen. Virol. 82:2001;813-820.
15. Orvell C., Unge T., Bhikhabhai R., Backbro K., Ruden U., Strandberg B., Wahren B., Fenyo E.M. Immunological characterization of the human immunodeficiency virus type 1 reverse transcriptase protein by the use of monoclonal antibodies. J. Gen. Virol. 72:1991;1913-1918.
16. Snowden W., Coughlan N., Tisdale M., Stammers D.K. Isolation and characterization of monoclonal antibodies raised against the reverse transcriptase of human immunodeficiency virus type 2 and cross-reactivity with that of type 1. J. Acquir. Immune Defic. Syndr. 6:1993;1187-1193.
17. Szilvay A.M., Nornes S., Haugan I.R., Olsen L., Prasad V.R., Endresen C., Goff S.P., Helland D.E. Epitope mapping of HIV-1 reverse transcriptase with monoclonal antibodies that inhibit polymerase and RNase H activities. J. Acquir. Immune Defic. Syndr. 5:1992;647-657.
18. Wu J., Amandoron E., Li X., Wainberg M.A., Parniak M.A. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain. J. Biol. Chem. 268:1993;9980-9985.
19. Maciejewski J.P., Weichold F.F., Young N.S., Cara A., Zella D., Reitz M.S. Jr., Gallo R.C. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat. Med. 1:1995;667-673.
20. Iwahashi M., Milenic D.E., Padlan E.A., Bei R., Schlom J., Kashmiri S.V. CDR substitutions of a humanized monoclonal antibody (CC49): contributions of individual CDRs to antigen binding and immunogenicity. Mol. Immunol. 36:1999;1079-1091.
21. Gargano N., Biocca S., Bradbury A., Cattaneo A. Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family. J. Virol. 70:1996;7706-7712.
22. Griffiths A.D., Williams S.C., Hartley O., Tomlinson I.M., Waterhouse P., Crosby W.L., Kontermann R.E., Jones P.T., Low N.M., Allison T.J.et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13:1994;3245-3260.
23. Hoogenboom H.R., de Bruine A.P., Hufton S.E., Hoet R.M., Arends J.W., Roovers R.C. Antibody phage display technology and its applications. Immunotechnology. 4:1998;1-20.
24. Sevilya Z., Loya S., Hughes S.H., Hizi A. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits. J. Mol. Biol. 311:2001;957-971.
25. Avidan O., Loya S., Tonjes R.R., Sevilya Z., Hizi A. Expression and characterization of a recombinant novel reverse transcriptase of a porcine endogenous retrovirus. Virology. 307:2003;341-357.
26. Hizi A., Hughes S.H. Expression in Escherichia coli of a Moloney murine leukemia virus reverse transcriptase whose structure closely resembles the viral enzyme. Gene. 66:1988;319-323.
27. Neri D., Pini A., Nissim A. Antibodies from phage display libraries as immunochemical reagents. Methods Mol. Biol. 80:1998;475-500.
28. Hizi A., Tal R., Shaharabany M., Currens M.J., Boyd M.R., Hughes S.H., McMahon J.B. Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors. Antimicrob. Agents Chemother. 37:1993;1037-1042.
29. Hizi A., Joklik W.K. RNA-dependent DNA polymerase of avian sarcoma virus B77. I: Isolation and partial characterization of the alpha, beta2, and alphabeta forms of the enzyme. J. Biol. Chem. 252:1977;2281-2289.
30. Chaiken I., Rose S., Karlsson R. Analysis of macromolecular interactions using immobilized ligands. Anal. Biochem. 201:1992;197-210.
31. Monnet C., Laune D., Laroche-Traineau J., Biard-Piechaczyk M., Briant L., Bes C., Pugniere M., Mani J.C., Pau B., Cerutti M., Devauchelle G., Devaux C., Granier C., Chardes T. Synthetic peptides derived from the variable regions of an anti-CD4 monoclonal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells. J. Biol. Chem. 274:1999;3789-3796.
32. Gopalakrishnan V., Peliska J.A., Benkovic S.J. Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities. Proc. Natl. Acad. Sci. U. S. A. 89:1992;10763-10767.
33. Schier R., McCall A., Adams G.P., Marshall K.W., Merritt H., Yim M., Crawford R.S., Weiner L.M., Marks C., Marks J.D. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J. Mol. Biol. 263:1996;551-567.
34. Kuby J. Immunology. 3rd ed. 1997;Freeman, New York.
35. Knappik A., Ge L., Honegger A., Pack P., Fischer M., Wellnhofer G., Hoess A., Wolle J., Pluckthun A., Virnekas B. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J. Mol. Biol. 296:2000;57-86.
36. Hizi A., McGill C., Hughes S.H. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proc. Natl. Acad. Sci. U. S. A. 85:1988;1218-1222.
37. Hizi A., Hughes S.H., Shaharabany M. Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase. Virology. 175:1990;575-580.
38. Jacobo-Molina A., Arnold E. HIV reverse transcriptase structure-function relationships. Biochemistry. 30:1991;6351-6356.
39. Marasco W.A., LaVecchio J., Winkler A. Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS. J. Immunol. Methods. 231:1999;223-238.